BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 21118117)

  • 1. Manipulation of the host translation initiation complex eIF4F by DNA viruses.
    Walsh D
    Biochem Soc Trans; 2010 Dec; 38(6):1511-6. PubMed ID: 21118117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and functional characterization of eIF4F components and poly(A)-binding protein from Plasmodium falciparum.
    Tuteja R; Pradhan A
    Parasitol Int; 2009 Dec; 58(4):481-5. PubMed ID: 19751846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repressor binding to a dorsal regulatory site traps human eIF4E in a high cap-affinity state.
    Ptushkina M; von der Haar T; Karim MM; Hughes JM; McCarthy JE
    EMBO J; 1999 Jul; 18(14):4068-75. PubMed ID: 10406811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cap-dependent translation initiation in the early stage porcine parthenotes.
    Susor A; Jelínková L; Karabínová P; Torner H; Tomek W; Kovárová H; Kubelka M
    Mol Reprod Dev; 2008 Dec; 75(12):1716-25. PubMed ID: 18386287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meal feeding enhances formation of eIF4F in skeletal muscle: role of increased eIF4E availability and eIF4G phosphorylation.
    Vary TC; Lynch CJ
    Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E631-42. PubMed ID: 16263769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1.
    Connor JH; Lyles DS
    J Virol; 2002 Oct; 76(20):10177-87. PubMed ID: 12239292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation.
    Svitkin YV; Herdy B; Costa-Mattioli M; Gingras AC; Raught B; Sonenberg N
    Mol Cell Biol; 2005 Dec; 25(23):10556-65. PubMed ID: 16287867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
    Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
    RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recruitment of host translation initiation factor eIF4G by the Vaccinia Virus ssDNA-binding protein I3.
    Zaborowska I; Kellner K; Henry M; Meleady P; Walsh D
    Virology; 2012 Mar; 425(1):11-22. PubMed ID: 22280895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinated and selective recruitment of eIF4E and eIF4G factors for potyvirus infection in Arabidopsis thaliana.
    Nicaise V; Gallois JL; Chafiai F; Allen LM; Schurdi-Levraud V; Browning KS; Candresse T; Caranta C; Le Gall O; German-Retana S
    FEBS Lett; 2007 Mar; 581(5):1041-6. PubMed ID: 17316629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative proteomics identifies Gemin5, a scaffolding protein involved in ribonucleoprotein assembly, as a novel partner for eukaryotic initiation factor 4E.
    Fierro-Monti I; Mohammed S; Matthiesen R; Santoro R; Burns JS; Williams DJ; Proud CG; Kassem M; Jensen ON; Roepstorff P
    J Proteome Res; 2006 Jun; 5(6):1367-78. PubMed ID: 16739988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5'-Terminal Cap and Hairpin.
    Korneeva NL; Song A; Gram H; Edens MA; Rhoads RE
    J Biol Chem; 2016 Feb; 291(7):3455-67. PubMed ID: 26668315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.
    Boussemart L; Malka-Mahieu H; Girault I; Allard D; Hemmingsson O; Tomasic G; Thomas M; Basmadjian C; Ribeiro N; Thuaud F; Mateus C; Routier E; Kamsu-Kom N; Agoussi S; Eggermont AM; Désaubry L; Robert C; Vagner S
    Nature; 2014 Sep; 513(7516):105-9. PubMed ID: 25079330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new translational regulator with homology to eukaryotic translation initiation factor 4G.
    Imataka H; Olsen HS; Sonenberg N
    EMBO J; 1997 Feb; 16(4):817-25. PubMed ID: 9049310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of cap-dependent translation in mitosis.
    Pyronnet S; Dostie J; Sonenberg N
    Genes Dev; 2001 Aug; 15(16):2083-93. PubMed ID: 11511540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation of eIF4F complex in Junin virus infection: blockage of eIF4E does not impair virus replication.
    Linero F; Welnowska E; Carrasco L; Scolaro L
    Cell Microbiol; 2013 Oct; 15(10):1766-82. PubMed ID: 23601822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
    Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
    Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA aptamers to mammalian initiation factor 4G inhibit cap-dependent translation by blocking the formation of initiation factor complexes.
    Miyakawa S; Oguro A; Ohtsu T; Imataka H; Sonenberg N; Nakamura Y
    RNA; 2006 Oct; 12(10):1825-34. PubMed ID: 16940549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement of the eukaryotic translation initiation factor 4F complex in hepatitis E virus replication.
    Zhou X; Xu L; Wang Y; Wang W; Sprengers D; Metselaar HJ; Peppelenbosch MP; Pan Q
    Antiviral Res; 2015 Dec; 124():11-9. PubMed ID: 26526587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of translation-initiation in CHO-K1 cells by rapamycin-induced heterodimerization of engineered eIF4G fusion proteins.
    Schlatter S; Senn C; Fussenegger M
    Biotechnol Bioeng; 2003 Jul; 83(2):210-25. PubMed ID: 12768627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.